Several leading cancer research centres have partnered to launch Juno Therapeutics, a cancer immunotherapy startup, which has received one of the largest series A rounds in history. Seattle-based Fred Hutchinson Cancer Research Centre and the Seattle Children’s Research Institute partnered on the New York City-based Memorial Sloan-Kettering Cancer Centre (MSKCC) to launch the venture. Investors…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
